Opendata, web and dolomites

PIPER SIGNED

Printing of Ultra-Thin, Flexible Perovskite Solar Cells and its Commercial Application

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "PIPER" data sheet

The following table provides information about the project.

Coordinator
SAULE SPOLKA AKCYJNA 

Organization address
address: ULICA POSTEPU 14B
city: WARSAW
postcode: 02 767
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Poland [PL]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2020-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SAULE SPOLKA AKCYJNA PL (WARSAW) coordinator 50˙000.00

Map

 Project objective

The impact of buildings to European final energy consumption has been assessed at 40%, making the building stock responsible for 36% of CO2 emissions. The reduction of energy consumption in buildings is the focus of the European 2020 strategy. EU’s essential policy instruments that encourage energy efficiency, retrofit measures and renewable production are: the Energy Efficiency Directive (EED), the Energy Performance of Building Directive (EPBD and EPBD recast) and the Renewable Energy Directive (RED). One of the major initiatives promoted by the EPBD recast is the implementation of nearly zero energy buildings (NZEBs) as the building objective from 2018 onwards. In the US, as well, several states’ strategic plans stipulate that all new residential buildings must be zero-net-energy (ZNE) by 2020, all new commercial buildings - by 2030, and 50% of existing commercial buildings must be retrofitted to ZNE by 2030. However currently available technologies pose challenges to reaching these objectives in cost-effective way. As an example, photovoltaic devices which bring high hopes and expectations to NZEBs, can currently only cover roofs, not allowing to optimally use the majority of building surface. They only generate energy from direct natural light and cannot be used on existing buildings without the need of severe structure modifications. Similar challenges (compliance with regulations, search for optimal efficiency-cost ratio, need for constant performance improvement while maintaining aesthetic features) are also faced by many other industries (automobile, aeronautics, consumer goods – electronics, clothing, etc.)

Saule Sp. z o. o. (Saule Technologies) aims to address these challenges by introducing the first-on-the-market perovskite solar cells (PSC) which are efficient, flexible, semi-transparent and inexpensive solar panels.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PIPER" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PIPER" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

TuneFork (2018)

Mobile technology that brings personalized audio into your life

Read More  

PrasinoMed (2018)

First in the world ecological and sustainable cream for wound care, based on microalgaprasinococcus capsulatus

Read More  

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More